Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study

References

• LieJAortic and extracranial large vessel giant cell arteritis: a review of 72 cases with histopathologic documentationSemin Arthritis Rheum19952464224317667646
   PubMed Web of Science ®Google Scholar
• De SmitEPalmerAJHewittAWProjected worldwide disease burden from giant cell arteritis by 2050J Rheumatol201542111912525362658
   PubMed Web of Science ®Google Scholar
• GildenDWhiteTKhmelevaNPrevalence and distribution of VZV in temporal arteries of patients with giant cell arteritisNeurology201584191948195525695965
   PubMed Web of Science ®Google Scholar
• NagelMAWhiteTKhmelevaNAnalysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritisJAMA Neurol201572111281128726349037
   PubMed Web of Science ®Google Scholar
• GildenDNagelMAVaricella zoster virus and giant cell arteritisCurr Opin Infect Dis201629327527926871403
   PubMed Web of Science ®Google Scholar
• MahrAAoubaARichebéPGonzalez-ChiappeSÉpidémiologie et histoire naturelle de l’artérite à cellules géantes (Horton). [Epidemiology and natural history of giant cell arteritis]Rev Med Interne20173810663669 French28457683
   PubMed Web of Science ®Google Scholar
• KobayashiSYanoTMatsumotoYClinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide surveyArthritis Rheum200349459459812910568
   PubMed Web of Science ®Google Scholar
• KermaniTAKennethJWarringtonKJLarge-vessel involvement in giant cell arteritis: a population-based cohort study of the incidence-trends and prognosisAnn Rheum Dis201372121989199423253927
   PubMed Web of Science ®Google Scholar
• United NationsWorld population prospects: The 2015 revision, volume I, comprehensive tablesNew York2015 ST/ESA/SER.A/379. Available from: https://esa.un.org/unpd/wpp/publications/Files/WPP2015_Volume-I_Comprehensive-Tables.pdfAccessed August 01, 2017
   Google Scholar
• Gonzalez-GayMAVazquez-RodriguezTRLopez-DiazMJMiranda-FilloyJAGonzalez-JuanateyCMartinJLlorcaJEpidemiology of giant cell arteritis and polymyalgia rheumaticaArthritis Rheum200961101454146119790127
   PubMed Web of Science ®Google Scholar
• MoiseevSNovikovPSmitienkoIShchegolevaEGiant cell arteritis, infections and biologicsAnn Rheum Dis2017769e2928057665
   PubMed Web of Science ®Google Scholar
• CicciaFRizzoAFerranteANew insights into the pathogenesis of giant cell arteritisAutoimmun Rev201716767568328479485
   PubMed Web of Science ®Google Scholar
• SamsonMCorbera-BellaltaMAudiaSPlanas-RigolEMartinLCidMCBonnotteBRecent advances in our understanding of giant cell arteritis pathogenesisAutoimmun Rev201716883384428564617
   PubMed Web of Science ®Google Scholar
• SchönrichGRafteryMJDendritic cells as Achilles’ heel and Trojan horse during varicella zoster virus infectionFront Microbiol2015641726005438
   PubMed Web of Science ®Google Scholar
• GildenDWhiteTKhmelevaNKatzBJNagelMABlinded search for varicella zoster virus in giant cell arteritis (GCA)-positive and GCA-negative temporal arteriesJ Neurol Sci201636414114327084233
   PubMed Web of Science ®Google Scholar
• MitchellBMFontRLDetection of varicella zoster virus DNA in some patients with giant cell arteritisInvest Opthalmol Vis Sci2001421125722577
   Web of Science ®Google Scholar
• MuratoreFCrociSTamagniniINo detection of varicella-zoster virus in temporal arteries of patients with giant cell arteritisSemin Arthritis Rheum201747223524028274481
   PubMed Web of Science ®Google Scholar
• KennedyPGGrinfeldEEsiriMMAbsence of detection of varicella-zoster virus DNA in temporal artery biopsies obtained from patients with giant cell arteritisJ Neurol Sci20032151–2272914568124
   PubMed Web of Science ®Google Scholar
• Helweg-LarsenJTarpBObelNBaslundBNo evidence of parvovirus B19, chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritisRheumatology (Oxford)200241444544911961176
   PubMed Web of Science ®Google Scholar
• Rodriguez-PlaABosch-GilJAEchevarria-MayoJENo detection of parvovirus B19 or herpesvirus DNA in giant cell arteritisJ Clin Virol2004311111515288607
   PubMed Web of Science ®Google Scholar
• Álvarez-LafuenteRFernández-GutiérrezBJoverJAHuman parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reactionAnn Rheum Dis200564578078215834059
   PubMed Web of Science ®Google Scholar
• NordborgCNordborgEPetursdottirVLaGuardiaJMahalingamRWellishMGildenDHSearch for varicella zoster virus in giant cell arteritisAnn Neurol19984434134149749614
   PubMed Web of Science ®Google Scholar
• PisapiaDJLaviEVZV, temporal arteritis, and clinical practice: False positive immunohistochemical detection due to antibody cross-reactivityExp Mol Pathol2016100111411526688577
   PubMed Web of Science ®Google Scholar
• SchäferVSKermaniTACrowsonCSIncidence of herpes zoster in patients with giant cell arteritis: a population-based cohort studyRheumatology (Oxford)201049112104210820627970
   PubMed Web of Science ®Google Scholar
• RheeRLGraysonPCMerkelPATomassonGInfections and the risk of incident giant cell arteritis: a population-based, case-control studyAnn Rheum Dis20177661031103527895041
   PubMed Web of Science ®Google Scholar
• EnglandBRMikulsTRXieFYangSChenLCurtisJHerpes zoster and the risk of incident giant cell arteritisArthritis Rheumatol201769122351235828853238
   PubMed Web of Science ®Google Scholar
• KawaiKGebremeskelGAcostaCJSystematic review of incidence and complications of herpes zoster: towards a global perspectiveBMJ Open201446e004833
   PubMed Web of Science ®Google Scholar
• WingSRiderLGJohnsonJRMillerFWMattesonELCrowsonCSGabrielSEDo solar cycles influence giant cell arteritis and rheumatoid arthritis incidence?BMJ Open2015155e006636
   Google Scholar
• OxmanMNLevinMJJohnsonGRA vaccine to prevent herpes zoster and postherpetic neuralgia in older adultsN Engl J Med2005352222271228415930418
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and PreventionWhat everyone should know about shingles vaccineCDC2016 Available from: https://www.cdc.gov/vaccines/vpd/shingles/public/index.htmlAccessed December 8, 2017
   Google Scholar
• European Medicines AgencyZostavax European public assessment reportEuropean Medicines Agency (EMEA)2006 Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000674/WC500053457.pdfAccessed December 8, 2017
   Google Scholar
• newswire.ca [homepage on the Internet]ZOSTAVAX(TM) approved in Canada – The first and only vaccine for the prevention of shinglesCISION News Wire2008 Available from: http://www.newswire.ca/news-releases/zostavaxtm-approved-in-canada---the-first-and-only-vaccine-for-the-prevention-of-shingles-536564411.htmlAccessed December 8, 2017
   Google Scholar
• LanganSMSmeethLMargolisDJThomasSLHerpes zoster vaccine effectiveness against incident herpes zoster and post-herpetic neuralgia in an older US population: a cohort studyPLoS Med2013104e100142023585738
   PubMed Web of Science ®Google Scholar
• NHS EnglandEnhanced service specification Shingles (catch-up) vaccination programme 2014NHS England gateway reference: 01773 Available from: https://www.england.nhs.uk/wp-content/uploads/2014/06/shingles-serv-spec.pdfAccessed August 01, 2017
   Google Scholar
• immunise.health.gov.au [homepage on the Internet]Immunise Australia ProgramAustralian Government Department of Health2016 Available from: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/IT0213.cntAccessed December 8, 2017
   Google Scholar
• news.ontario.ca [homepage on the Internet]Ontario making shingles vaccine free for seniorsGovernment of Ontario2016 Available from: https://news.ontario.ca/mohltc/en/2016/09/ontario-making-shingles-vaccine-free-for-seniors.htmlAccessed December 8, 2017
   Google Scholar
• DiamantopoulosAMyklebustGWigaardEAmundsenLSoldalDMHaugebergGThe incidence rate of giant cell arteritis in southern Norway is lower than previously reported: A result of temporal variations or a sign of a true shift in incidence rates?Paper presented at: EULAR 2014: Scientific AbstractsJune 13; 2014Paris, France
   Google Scholar
• RimselieneGVainioKGiboryMSalamancaBVFlemEVaricella-zoster virus susceptibility and primary healthcare consultations in NorwayBMC Infect Dis20161625427266273
   PubMed Web of Science ®Google Scholar
• FranzénPSutinenSvon KnorringJGiant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984–1988J Rheumatol19921922732761629827
   PubMed Web of Science ®Google Scholar
• KarhunenMLeinoTSaloHDavidkinIKilpiTAuranenKModelling the impact of varicella vaccination on varicella and zosterEpidemiol Infect2010138446948119796447
   PubMed Web of Science ®Google Scholar
• MohammadAJNilssonJJacobssonLTMerkelPATuressonCIncidence and mortality rates of biopsy-proven giant cell arteritis in southern SwedenAnn Rheum Dis201574699399724442881
   PubMed Web of Science ®Google Scholar
• StudahlMPetzoldMCasselTDisease burden of herpes zoster in Sweden – predominance in the elderly and in women – a register based studyBMC Infect Dis20131358624330510
   PubMed Web of Science ®Google Scholar
• SmeethLCookCHallAJIncidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001Ann Rheum Dis20066581093109816414971
   PubMed Web of Science ®Google Scholar
• BrissonMEdmundsWJEpidemiology of varicella-zoster virus in England and WalesJ Med Virol200370Suppl 1S9S1412627480
   PubMedGoogle Scholar
• ChandranAKUdayakumarPDCrowsonCSWarringtonKJMattesonELThe incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950–2009Scand J Rheumatol201544321521825606666
   PubMed Web of Science ®Google Scholar
• KawaiKYawnBPWollanPHarpazRIncreasing incidence of herpes zoster over a 60-year period from a population-based studyClin Infect Dis201663222122627161774
   PubMed Web of Science ®Google Scholar
• Gonzalez-GayMAMiranda-FilloyJALopez-DiazMJGiant cell arteritis in northwestern Spain: A 25-year epidemiologic studyMedicine (Baltimore)2007862616817435586
   PubMed Web of Science ®Google Scholar
• Morant-TalamanteNDiez-DomingoJMartínez-ÚbedaSPuig-BarberáJAlemán-SánchezSPérez-BrevaLHerpes zoster surveillance using electronic databases in the Valencian Community (Spain)BMC Infect Dis20131346324094135
   PubMed Web of Science ®Google Scholar
• Abdul-RahmanAMMoltenoACBBevinTHThe epidemiology of giant cell arteritis in Otago, New Zealand: a 9-year analysisN Z Med J201112413294452
   Google Scholar
• ReidJSAh WongBHerpes zoster (shingles) at a large New Zealand general practice: incidence over 5 yearsN Z Med J201412714075660
   Google Scholar
• Bas-LandoMBreuerGSBerkunYMatesMSonnenblickMNesherGThe incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuationsClin Exp Rheumatol2007251 Suppl 44S15S1717428357
   PubMed Web of Science ®Google Scholar
• WeitzmanDShavitOSteinMCohenRChodickGShalevVA population based study of the epidemiology of herpes zoster and its complicationsJ Infect201367546346923872209
   PubMed Web of Science ®Google Scholar
• RamsteadCLPatelADGiant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998–2003Can J Ophthalmol200742229529817392855
   PubMed Web of Science ®Google Scholar
• TanuseputroPZagorskiBChanKJKwongJCPopulation-based incidence of herpes zoster after introduction of a publicly funded varicella vaccination programVaccine201129478580858421939721
   PubMed Web of Science ®Google Scholar
• BarrierJPionPMassariRPeltierPRojouanJGrolleauJYApproche epidemiologique de la maladie de Horton dans le departement de Loire-Atlantique 110 cas en 10 ans (1970–1979). [Epidemiologic approach to Horton’s disease in the department of Loire-Atlantique. 110 cases in 10 years (1970–1979)]Rev Med Interne1982311320 French7100693
   PubMedGoogle Scholar
• Gonzalez ChiappeSSarazinMTurbelinCHerpes zoster: Burden of disease in FranceVaccine201028507933793820946861
   PubMed Web of Science ®Google Scholar
• CatanosoMMacchioniPBoiardiLIncidence, prevalence, and survival of biopsy-proven giant cell arteritis in Northern Italy during a 26-year periodArthritis Care Res (Hoboken)201769343043827214746
   PubMed Web of Science ®Google Scholar
• GialloretiLEMeritoMPezzottiPEpidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based studyBMC Infect Dis20101023020682044
   PubMed Web of Science ®Google Scholar
• DunstanELesterSLRischmuellerMEpidemiology of biopsy-proven giant cell arteritis in South AustraliaIntern Med J2014441323924118799
   PubMed Web of Science ®Google Scholar
• SteinANBrittHHarrisonCConwayELCunninghamAMacintyreCRHerpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and olderVaccine200927452052919027048
   PubMed Web of Science ®Google Scholar
• Reinhold-KellerEHerlynKWagner-BastmeyerRGrossWLStable incidence of primary systemic vasculitides over five years: Results from the German vasculitis registerArthritis Rheum2005531939915696553
   PubMed Web of Science ®Google Scholar
• UltschBSiedlerARieckTReinholdTKrauseGWichmannOHerpes zoster in Germany: quantifying the burden of diseaseBMC Infect Dis20111117321679419
   PubMed Web of Science ®Google Scholar
• ToyamaNShirakiKSociety of the Miyazaki Prefecture DermatologistsEpidemiology of herpes zoster and its relationship to varicella in Japan: a 10-year survey of 48,388 herpes zoster cases in Miyazaki prefectureJ Med Virol200981122053205819856466
   PubMed Web of Science ®Google Scholar